Public Page
BloodScan Biotech Inc.
BloodScan invented Labyrinth One, the first and only liquid biopsy system benchmarked to tissue biopsy. It isolates rare CTCs early and with unmatched precision, delivering >95% recovery and >99.9999% purity. Fully automated and label-free, it provides real-time insights into cancer progression and treatment response—bringing precision oncology closer to patients worldwide.
Healthtech / HealthcarePre-ATaiwan
Interested in BloodScan Biotech Inc.?
Request access to the full data room to review financials, documents and due diligence materials.